Careers  |  Sign In  |  Register  |   Twitter

Latest in Hematology-Oncology

A new study shows that the aromatase inhibitor letrozole can prevent late recurrence of breast cancer. References and Resources Goss P, et al. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen. Journal of Clinical...
Statin use at the time of ovarian cancer surgery was associated with a 50% increase in the duration of progression-free survival and with more than a year of additional survival. References and Resources Elmore RG, et al. Impact of statin therapy on outcome in epithelial cancer. Gynecol Oncol. 2008;...
The Oncologic Drug Advisory Committee said the FDA should mandate a restricted distribution system for cancer patients given erythropoiesis-stimulating agents. References and Resources FDA.gov Sponsored by The Doctor's...